Enteral Nutrition Market- Creating a positive impact during the COVID-19 crisis

The global intestinal nutrition market size was valued at $5,661.6 million in 2017, and is expected to reach $10,478.0 Million in 2025, with an average annual growth rate of 7.9% from 2018 to 2025. Patients who are unable to swallow food or obtain sufficient nutrition by eating or drinking. These medical devices deliver drugs and nutrients directly to the stomach, duodenum, or jejunum through the nose, mouth, or direct transdermal route.

know more: https://www.alliedmarketresearch.com/enteral-nutrition-market

Increased prevalence of multiple chronic diseases such as cancer and neurological disorders worldwide, a surge in the adoption of gut nutrition for parenteral nutrition, an increase in the elderly population, and an increase in malnutrition cases drive market growth. However, stringent government regulations and careless dropouts of the tube leading to accidental disability and death hinder the market's growth. Conversely, the development of new products with fewer side effects and untapped market potential in emerging economies is expected to provide favorable growth opportunities for the global gut nutrition market.

Click Here to Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/5049

According to the WHO, the number of people diagnosed with diabetes rose from 180 million in 1980 to 422 million in 2014. In addition, the prevalence of diabetes in adults over 18 years of age increased from 4.7% in 1980 to 8.5% in 2014. This pattern of growth is more evident in low and middle income countries. Hence, the increasing prevalence of diabetes drives the growth of the gut nutrition market.

According to U.S. National Cancer Institute data, 1,735,350 new cancers are expected to be diagnosed in the U.S. by the end of 2018. Also, according to Centers for Disease Control and Prevention (CDC) data, all adults around the world (approximately 117 million people) suffered from one or more chronic diseases in 2012, and diabetes is the most common chronic disease. Therefore, it is expected that the rapidly increasing number of cancer cases around the world will increase the adoption of the enteric nutrition system, fueling the growth of the enteric nutrition market.

Worldwide, the elderly population vulnerable to disorders such as cardiovascular, stroke, diabetes, stomach and bowel disease has increased tremendously over the past few years. According to data released by the U.S. Census Bureau, about 617.1 million of the world's population in 2015 fall into the age group of 65 and older. The number of senior citizens is expected to increase by 60% in just 15 years, and is expected to increase further over the next 20 years. The rapid increase in the elderly population is one of the main drivers of the intestinal nutrition market because it is very vulnerable to various diseases due to reduced immunity and degeneration.

Intestinal nutrition is preferred over parenteral nutrition due to improved safety and ease of access. In addition, the use of percutaneous jejunostomy, percutaneous double duct gastrointestinal resection, and nostril tract has become commonplace with good safety records. Therefore, due to the many benefits of intestinal feeding, it is very acceptable as a home feeding regimen.

Emerging economies in the Asia Pacific region provide profitable growth opportunities for market participants due to improved healthcare infrastructure and increased demand for better healthcare services in the region. Moreover, the increasing prevalence of several chronic diseases in developing countries increases the demand for gut nutrition. In addition, increasing medical spending in the region is expected to accelerate the growth of the intestinal nutrition market.

Digital marketing is favored over traditional ad formats due to the increasing penetration of the Internet and social media. Mobile apps and social media will play an important role in helping emerging markets like India catch up with the technological advantage of peers like China.

Indian pharmaceutical companies started investing in digital platforms for marketing. In 2016, India's multinational pharmaceutical company Sun Pharmaceuticals Industries Ltd. launched RespiTrack, a mobile app with features such as drug alerts, pre-programmed alerts, wireless review by doctors, and more.

British pharmaceutical company GlaxoSmithKline plc equipped its employees with iPads to distribute real-time information on advances in the field of therapy. Additionally, the company has used platforms such as webinars, video chats, information portals, and Viva for doctors to drive sales.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5049

Key Results of the Enteral Nutrition Market:
• Diabetes patient segment by protein composition

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.